Macrophage NCOR1 Deficiency Ameliorates Myocardial Infarction and Neointimal Hyperplasia in Mice.
Lin‐Juan Du,Jian‐Yong Sun,Wu‐Chang Zhang,Yong‐Li Wang,Hong Zhu,Ting Liu,Ming‐Zhu Gao,Chen Zheng,Yu‐Yao Zhang,Yuan Liu,Yan Liu,Shuai Shao,Xue‐Qing Zhang,Qibin Leng,Johan Auwerx,Sheng‐Zhong Duan
DOI: https://doi.org/10.1161/jaha.120.015862
IF: 6.106
2020-07-30
Journal of the American Heart Association
Abstract:Background NCOR1 (nuclear receptor corepressor 1) is an essential coregulator of gene transcription. It has been shown that NCOR1 in macrophages plays important roles in metabolic regulation. However, the function of macrophage NCOR1 in response to myocardial infarction (MI) or vascular wire injury has not been elucidated. Methods and Results Here, using macrophage Ncor1 knockout mouse in combination with a mouse model of MI, we demonstrated that macrophage NCOR1 deficiency significantly reduced infarct size and improved cardiac function after MI. In addition, macrophage NCOR1 deficiency markedly inhibited neointimal hyperplasia and vascular remodeling in a mouse model of arterial wire injury. Inflammation and macrophage proliferation were substantially attenuated in hearts and arteries of macrophage Ncor1 knockout mice after MI and arterial wire injury, respectively. Cultured primary macrophages from macrophage Ncor1 knockout mice manifested lower expression of inflammatory genes upon stimulation by interleukin‐1β, interleukin‐6, or lipopolysaccharide, together with much less activation of inflammatory signaling cascades including signal transducer and activator of transcription 1 and nuclear factor‐κB. Furthermore, macrophage Ncor1 knockout macrophages were much less proliferative in culture, with inhibited cell cycle progression compared with control cells. Conclusions Collectively, our data have demonstrated that NCOR1 is a critical regulator of macrophage inflammation and proliferation and that deficiency of NCOR1 in macrophages attenuates MI and neointimal hyperplasia. Therefore, macrophage NCOR1 may serve as a potential therapeutic target for MI and restenosis. Nonstandard Abbreviations and Acronyms BrdU bromodeoxyuridine CM conditioned medium LC littermate control MI myocardial infarction MNKO macrophage Ncor1 knockout NCOR1 nuclear receptor corepressor 1 PI propidium iodide VSMCs vascular smooth muscle cells Clinical Perspective What Is New? Deletion of NCOR1 (nuclear receptor corepressor 1) in macrophages protects against myocardial injury after myocardial infarction and improves neointimal hyperplasia. NCOR1 deficiency inhibits macrophage proliferation. What Are the Clinical Implications? Macrophage NCOR1 is a potential therapeutic target for myocardial infarction and restenosis. Cardiovascular diseases, particularly ischemic heart disease, remain the leading cause of mortality and morbidity worldwide. 1 Myocardial infarction (MI) resulting from sudden interruption of blood supply to the myocardium causes rapid death of cardiomyocytes. One of the most common treatments for MI is percutaneous coronary intervention. However, vascular injury caused by percutaneous coronary intervention may lead to restenosis, which may require revascularization. 2 A long‐term study with a median of 5 years of follow‐up has shown that even after the introduction of drug‐eluting stents, the rate of revascularization remains 16.5%, comparing with 19.8% for bare‐metal stents. 3 Furthermore, currently available drug‐eluting stents does not improve a primary outcome, death from any cause and nonfatal spontaneous MI, compared with bare‐metal stents. 3 Eventually, a large proportion of surviving MI patients develop heart failure, particularly after repeated interventional therapy. Therefore, new therapeutic strategies for both MI and restenosis are still in urgent need. Inflammation plays important roles during MI and vascular injury. Anti‐inflammatory strategy has been proved beneficial for patients with MI and high level of C‐reactive protein.<a class="tab-link" href="#jah35303-bib-0 -Abstract Truncated-
cardiac & cardiovascular systems